Mortality within 30 days of immunotherapy (checkpoint inhibitors) in metastatic cancer patients treated at Australian tertiary cancer center.
Hiren Mandaliya(Lake Macquarie Private Hospital), Girish Mallesara(Calvary Mater Newcastle Hospital), Christopher Oldmeadow(Hunter Medical Research Institute), Jack Faulkner(Hunter Medical Research Institute), Gaik Tin Quah(Calvary Mater Newcastle Hospital), Sang Kim(Macquarie University), James E. Carlton(Tata Memorial Hospital), Sandy Tun Min(Calvary Mater Newcastle Hospital)
Cited by 5
Related Papers
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
|Nature Genetics|2018|1.5k
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
|The American Journal of Human Genetics|2018|453
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
|Translational Lung Cancer Research|2019|392
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial
|Nature Medicine|2023|135
Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function
|Nature Communications|2018|130